Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Thielsen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos One|June 23, 2026
Effect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trialSofie Jespersen, Asmita Fritt-Rasmussen, Cody Garett Durrer, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Acta Dermato-Venereologica|December 14, 2016
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert MeetingLine Raaby, Claus Zachariae, Monika Østensen, et al.
Plos One|December 10, 2020
Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAsJacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, et al.
Plos One|December 2, 2014
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutationsChristina Sølund, Henrik Krarup, Santseharay Ramirez, et al.
Journal of Viral Hepatitis|November 1, 2020
Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcomeUlrik Fahnøe, Martin S Pedersen, Christina Sølund, et al.
Journal of Hepatocellular Carcinoma|October 25, 2022
Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected PopulationSigne Bollerup, Frederik Engsig, Sofie Hallager, et al.
Journal of Viral Hepatitis|May 28, 2022
Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in DenmarkSigne Bollerup, Sofie Hallager, Frederik Engsig, et al.
Clinical Epidemiology|July 26, 2022
Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort StudyFrederik Faergemann Lau, Signe Bollerup, Frederik Engsig, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitisRikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|June 23, 2026
Effect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trialSofie Jespersen, Asmita Fritt-Rasmussen, Cody Garett Durrer, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Acta Dermato-Venereologica|December 14, 2016
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert MeetingLine Raaby, Claus Zachariae, Monika Østensen, et al.
Plos One|December 10, 2020
Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAsJacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, et al.
Plos One|December 2, 2014
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutationsChristina Sølund, Henrik Krarup, Santseharay Ramirez, et al.
Journal of Viral Hepatitis|November 1, 2020
Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcomeUlrik Fahnøe, Martin S Pedersen, Christina Sølund, et al.
Journal of Hepatocellular Carcinoma|October 25, 2022
Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected PopulationSigne Bollerup, Frederik Engsig, Sofie Hallager, et al.
Journal of Viral Hepatitis|May 28, 2022
Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in DenmarkSigne Bollerup, Sofie Hallager, Frederik Engsig, et al.
Clinical Epidemiology|July 26, 2022
Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort StudyFrederik Faergemann Lau, Signe Bollerup, Frederik Engsig, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitisRikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep, et al.
Pageof 3